Status:
ACTIVE_NOT_RECRUITING
Choroidal Response to Novel Spectacle Lens to Control Myopia Progression
Lead Sponsor:
SightGlass Vision, Inc.
Collaborating Sponsors:
University of Waterloo
Conditions:
Myopia, Progressive
Eligibility:
All Genders
6-10 years
Phase:
NA
Brief Summary
Diurnal variations in the thickness of the choroid have been reported in the literature, and, more recently, the role of the choroid has been studied with respect to its role in myopia (near-sightedne...
Detailed Description
Diurnal variations in the thickness of the choroid have been reported in the literature , and, more recently, the role of the choroid has been studied with respect to its role in myopia (near-sightedn...
Eligibility Criteria
Inclusion
- Participating in the CPRO-1802-001 (Cypress\_SG) study at CORE
- Read and signed an Assent and their parent/guardian has signed an information consent letter
Exclusion
- Transient health condition which may affect the eye(s) (e.g. a common cold, active allergies, fatigue, etc;)
Key Trial Info
Start Date :
December 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03818880
Start Date
December 18 2018
End Date
March 31 2026
Last Update
December 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Ocular Research and Education
Waterloo, Ontario, Canada, N2L 3G1